Dr. Galson
Dr. Galson
action advise assess benefits carefully determine evaluate further potential providers risks whether
We're working to evaluate the potential risks and determine whether there is a need for further action. In the meantime, we advise providers to carefully assess the benefits and risks of the drug for their patients.
fatal forms found illness needed offer option patients product progress rare suffering treatment
This new product will offer a much needed treatment option for patients suffering from this rare illness that, in some cases, has been found to progress to fatal forms of leukemia.